INTRODUCTION
Gastro-Intestinal Stromal Tumor (GIST) is a nonepithelial, mesenchymal tumor. They most commonly originate from the stomach or small intestine, rarely in the omentum.
The term GIST was first used in 1983 by Mazur and Clark to encompass gastrointestinal non-epithelial neoplasms that lacked the immunohistochemical features of Schwann cells and did not have the ultrastructural characteristics of smooth muscle cells. 1 Gastrointestinal stromal tumour is a mesenchymal neoplasm in which the line of differentiation recapitulates the cells of Cajal and has a broad spectrum of biological behavior. They express CD117, a c-kit proto-oncogene protein, and show gain of function mutation of c-kit gene that encodes a growth factor receptor with tyrosine kinase activity. Extra-Gastrointestinal Stromal Tumour (EGIST) is histologically and immunohistochemically similar to their gastrointestinal counterpart but they have an aggressive course resembling small intestinal stromal tumors and they have no or little connection to the abdominal wall or serosal surface of the gastrointestinal tract. 3 Mesenchymal tumours of omentum, mesentery and retroperitoneum with immunohistochemical features of the GISTs are classified as extragastrointestinal stromal tumors because these organs have no connection with the wall of the gastrointestinal tract. The incidence of EGISTS is less than 10% of the GISTs group 3 and because of their rarity, clinicopathologic and immunohistochemical features of EGISTs are not fully elucidated.
3

CASE REPORT
A 65 year female presented with complaints of abdominal pain, vomiting and abdominal lump for 2 months duration. Clinical and laboratory examination showed no significant abnormalities. Imaging modalities, including computed tomography and magnetic resonance imaging reveals a large heterogenous soft tissue mass lesion with foci of calcification noted with air pockets and necrotic areas and size of around 10.9x9.8x11.3 cm in the pelvis (Figure 1 ). Upper gastrointestinal endoscopy shows normal gastric mucosa. Scope was passed upto terminal ileum which shows normal mucosal study. Laparotomy was done and found that well defined mass lesions of variable size and consistency were found arising from the mesentery behind urinary bladder, above uterus and above the ovaries. Largest mass measuring 15x10x6 cm and smallest measuring 2x2x1 cm with restricted mobility. Antimesenteric surface of ileum was almost merging with the mass lesion with impending obstruction. About 200 ml of hemoperitoneum was found. Entire surface of peritoneum, small bowel mesentery and colon were nodular. Omental mass imprint cytology was done and sent for cytology.
Imprint cytology revealed a cellular smear composed of round to polygonal plemorphic cells in diffuse sheets with abundant eosinophilic cytoplasm and hyperchromatic nuclei. Focal clusters of spindle shaped cells were also seen in a hemorrhagic background ( Figure  2 ). Impression was given as smear positive for malignancy with following possible differential diagnosis.
Adenocarcinomatous deposit/malignant extragastrointestinal stromal tumour (Epithelioid type). Subsequently patient was treated with side to side ileoileal anastomosis and omental biopsy taken. Omental biopsy was measuring 2.5x2x1 cm. in size. External surface was irregular. Cut surface showed a grey white lesion. Microscopic examination showed a neoplasm composed of fascicles of epithelioid cells having moderate eosinophilic cytoplasm with centrally placed round to oval nuclei separated by fibrous stroma admixed with congested blood vessels. High cellularity, a high mitotic count (>5/ 50 hpf) and marked nuclear atypia suggested the high risk nature of the tumour. However, necrosis was absent. A diagnosis of malignant epithelioid extragastrointestinal stromal tumour was made ( Figure  3 ). 
DISCUSSION
Extra-gastrointestinal stromal tumour is a rare stromal tumour that occurs outside the GIT and comprises about 5-7% of all the GISTs. 4 Most of the EGIST cases are located in the mesentry, omentum and retroperitoneum. 3, 5 There are rare cases of EGIST localization in the posterior mediastinum, liver, gallbladder, pancreas, urinary bladder, inguinal hernia sac, scrotum, uterus, fallopian tube and rectovaginal septum. [6] [7] [8] [9] [10] EGISTs are histologically and immunohistochemically similar to their gastrointestinal counterparts but are rare and have an aggressive course. Their histogenesis is said to be from the interstitial cells of Cajal, as these cells express CD-117. EGISTs also show positivity for CD-34 in 50% of the cases. A recent observation that the interstitial cells of Cajal do not express CD34 whereas the fibroblasts of Auerbach's plexus do, suggests that the stromal tumours may display hybrid features.
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The tumours which present as multiple nodules are usually metastatic from primary GIST and are confused with peritoneal carcinomatosis. 12 In our case, the tumour presented as multiple nodules and there was no evidence of any primary tumour in the gastrointestinal tract.
The main differential diagnoses which were considered in the present case were fibromatosis, smooth muscle tumours, neural tumours and malignant fibrous histiocytomas.
The distinction from fibromatosis is made primarily on the basis of morphology. Fibromatosis has low cellularity and it is composed of spindle cells lying in a collagenous stroma. Necrosis and mitotic activity is absent. Also, mesenteric fibromatoses are usually negative for CD-117. 13 Smooth muscle tumours and neural tumours are differentiated from EGISTs on the basis of both morphology and immunohistochemistry. Both of these tumours are negative for CD-117. 14 The Storiform pattern of the tumour might be confused with that of Malignant Fibrous Histiocytoma (MFH). But, there was an absence of giant cells and CD-117 positivity favoured the diagnosis of EGIST.
When first detected, many cases of EGISTs can be accessed by a Fine Needle Aspiration Biopsy (FNAB) or imprint cytology. In our case, we performed a cytological diagnosis on imprint and the result was highly suspicious for the diagnosis of extragastrointestinal stromal tumor. Although GISTs primary in the gastrointestinal tract commonly metastasize to the omentum and mesentery, often as multiple nodules, GISTs may also occur as primary tumors outside of the gastrointestinal tract proper in other intra-abdominal locations, especially in the omentum and mesentery.
These tumors are composed of either purely rounded epitheloid cells (predominantly) or short fusiform cells in a fine fibrillary collagenous background. Rarely, mixed pattern is also encountered. Similar to GISTs, EGISTs also display varying amounts of stromal hyalinization, myxoid change and cyst formation. However skeinoid fibers, a common marker in GIST of the small bowel, are absent in this tumor.
DOG-1 (Discovered on GIST 1) has proved to be sensitive and specific for the diagnosis of GISTs when compared with C-kit, including cases of extragastrointestinal and metastatic GIST. DOG-1 expression was membranous and cytoplasmic. Immunohistochemistry in this case has shown diffuse positivity for DOG-1 marker.
This case emphasises that though it is a rare tumour, EGIST must be considered in the differential diagnosis of the mesenchymal tumours and that immunohistochemistry should be done to confirm the diagnosis. The prognostic values of the different parameters need to be discussed and each case must be followed properly. The behaviour of these tumours varies from being benign to highly malignant and so the correct assessment of the behaviour of the tumour is a must for the proper management of the patient.
